Pelizaeus-Merzbacher disease as a chromosomal disorder

Toshiyuki Yamamoto1, Keiko Shimojima

  • 1Institute for Integrated Medical Sciences, Tokyo Women's Medical University, Tokyo, Japan. yamamoto.toshiyuki@twmu.ac.jp

Congenital Anomalies
|March 14, 2013
PubMed

Insights

Pelizaeus-Merzbacher disease (PMD) is a rare genetic disorder affecting myelin. It is caused by alterations in the proteolipid protein 1 gene (PLP1), often involving duplications or other chromosomal rearrangements.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Pelizaeus-Merzbacher disease (PMD) is a congenital hypomyelination disorder.
  • It results from genetic alterations in the proteolipid protein 1 gene (PLP1), located on chromosome Xq22.2.

Purpose of the Study:

  • To elucidate the genetic basis and chromosomal abnormalities underlying Pelizaeus-Merzbacher disease.
  • To understand the correlation between specific PLP1 alterations and PMD phenotypes.

Main Methods:

  • Analysis of genetic alterations in the PLP1 gene.
  • Characterization of chromosomal rearrangements, including duplications, translocations, and triplications, involving the PLP1 locus.

Main Results:

  • Missense mutations in PLP1 are associated with the severe connatal form of PMD.
  • PLP1 duplications are found in two-thirds of PMD patients, presenting the classical form.
  • Other rare abnormalities like X-chromosome translocations and partial duplications involving PLP1 were identified.

Conclusions:

  • PMD is fundamentally a chromosomal disorder due to rearrangements around the PLP1 gene.
  • The genomic structure of the PLP1 locus, with its repetitive segments, predisposes it to these rearrangements.
  • Understanding these genetic and chromosomal factors is crucial for diagnosing and potentially treating PMD.

Related Concept Videos